NCT05048771

Brief Summary

Background: When a cancer is diagnosed in a child, the urgency is to take therapeutic actions. Children and their families face the reality of cancer and the reality of the treatments that, in addition to be overwhelming, might cause infertility. Immediately after the diagnosis, a fertility preservation consultation is proposed to discuss fertility preservation options. In practice, it is often difficult to organize. Several years after the end of treatments, a second information consultation is proposed to inform about fertility, evaluate the fertility status and propose a second line of Fertility Preservation when possible. The literature reflects a lack of knowledge regarding the degree of fertility-related distress among pediatric cancer patients as well as insufficient tools at the disposal of medical doctors and nurses to discuss about reproduction with children and young adolescents. Project objective: Understand how young cancer patients and their parents felt about sterility risk at the diagnostic time and now as cured adolescents. Patients \& Methods: 300 patients (15-25 years) from 5 different centers (20 patients per year and per center for 3 years) will be included in this study at the information consultation. They will be surveyed through self-administered questionnaires and semidirected interviews that will 1) retrieve perceptions and emotional being of children during the fertility preservation consultation; 2) assess the decision-making process of parents and family since the fertility preservation consultation through the patient's speech; 3) interview the patients about personal history and experience of cancer and consequences of potential fertility impairment and 4) survey the current experience and projections in the future and evaluate their reaction to the proposition of a second line of Fertility Preservation. Expected results: what points should the doctor / psychologist discuss with pediatric cancer survivors in response to their fertility stress? and how to do it? for better initial and follow-up care to improve their quality of life after cancer.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2021

Typical duration for all trials

Geographic Reach
1 country

5 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 25, 2021

Completed
7 days until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
16 days until next milestone

First Posted

Study publicly available on registry

September 17, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

September 17, 2021

Status Verified

September 1, 2021

Enrollment Period

2.2 years

First QC Date

August 25, 2021

Last Update Submit

September 8, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluate the impact of infertility on psychological health

    Patients will report the outcomes of the infertility risks on the questionnaire provided in this study. Positive and negative impacts will be questioned.

    december 2023

Secondary Outcomes (1)

  • Develop a decision aid tool for clinicians designed to increase referral for fertility preservation

    december 2023

Study Arms (1)

FERTITOP

300 patients (15-25 years) from 5 different hospitals (University Hospitals of Nancy, Strasbourg, Reims, Besançon, Dijon (France)) who have finished all cancer treatments for at least 2 years.

Other: Questionnaire

Interventions

Patients will be surveyed through self-administered questionnaires and semidirected interviews with a psychologist

Also known as: Interview
FERTITOP

Eligibility Criteria

Age15 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Adolescents and young adults treated for childhood cancer in one of the five hospital of the Great Est region or France having a follow-up by a pediatric oncologist.

You may qualify if:

  • age between 15 -25
  • having been diagnosed with cancer during childhood or adolescence,
  • having finished the treatments and being in remission for at least 2 years

You may not qualify if:

  • Recurrence of cancer at the time of the study
  • Lack of cognitive autonomy to be able to agree to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

University Hospital of Besançon

Besançon, France

Location

University Hospital of Dijon

Dijon, France

Location

University Hospital of Nancy, France

Nancy, 54000, France

Location

University hospital of Reims

Reims, France

Location

University hospital of Strasbourg

Strasbourg, France

Location

MeSH Terms

Conditions

InfertilityNeoplasms

Interventions

Surveys and QuestionnairesInterviews as Topic

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 25, 2021

First Posted

September 17, 2021

Study Start

September 1, 2021

Primary Completion

December 1, 2023

Study Completion

March 1, 2024

Last Updated

September 17, 2021

Record last verified: 2021-09

Locations